Acquired pure megakaryocytic aplasia: report of a single case treated with mycophenolate mofetil

Am J Hematol. 2007 Jul;82(7):650-1. doi: 10.1002/ajh.20895.

Abstract

Acquired pure megakaryocytic aplasia (APMA) is a rare disorder in the field of hematological diseases. We report the case of a patient with APMA treated with mycophenolate mofetil and review the literature associated with this. Until today, very few cases of APMA have been reported and the disease etiology still seems to be unclear. There have been no reported cases of treatment of APMA treated with mycophenolate mofetil.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Aged
  • Bone Marrow Diseases / drug therapy*
  • Bone Marrow Diseases / pathology*
  • Humans
  • Male
  • Megakaryocytes / drug effects*
  • Megakaryocytes / pathology*
  • Mycophenolic Acid / analogs & derivatives*
  • Mycophenolic Acid / therapeutic use
  • Platelet Count

Substances

  • Mycophenolic Acid